Literature DB >> 21715136

Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality.

Melda Turkoglu1, Emel Mirza2, Özlem Güzel Tunçcan3, Gökmen Umut Erdem2, Murat Dizbay3, Münci Yağcı4, Gülbin Aygencel2, Gülsan Türköz Sucak4.   

Abstract

PURPOSE: We investigated the characteristics of Acinetobacter baumannii infection in critically ill patients with hematologic malignancies.
MATERIALS AND METHODS: The prospectively collected data of patients with hematologic malignancies admitted to a medical intensive care unit of a university hospital from 2007 through 2010 were reviewed retrospectively.
RESULTS: One hundred twenty-eight patients were included in the study, among whom 35 (27%) developed 39 A baumannii infections. Pneumonia was the most common infection site of A baumannii. Presence of neutropenia, underlying hematologic malignancy, and the disease status did not affect the acquisition of the infection. Advancing age, prior exposure to aminoglycosides, central venous catheterization, and presence of nasogastric tube were the independent risk factors for the development of A baumannii infections. The mortality rate was higher in patients with A baumannii infections compared with the ones without (P = .009). However, in multivariate analysis, low Glasgow coma scale, prior immunosuppressive treatment, neutropenia, invasive mechanical ventilation, and severe sepsis were independently associated with mortality, whereas presence of A baumannii infection was not.
CONCLUSIONS: Despite the high mortality rate in critically ill patients with hematologic malignancies, presence of A baumannii infection was not an independent risk factor for mortality.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21715136     DOI: 10.1016/j.jcrc.2011.04.007

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  15 in total

1.  Severe Sepsis-Associated Morbidity and Mortality among Critically Ill Children with Cancer.

Authors:  Salim Aljabari; Alfred Balch; Gitte Y Larsen; Mark Fluchel; Jennifer K Workman
Journal:  J Pediatr Intensive Care       Date:  2018-12-21

2.  Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria.

Authors:  Maristela P Freire; Ligia C Pierrotti; Antonio E Zerati; Luciana Benites; Joaquim Mauricio da Motta-Leal Filho; Karim Y Ibrahim; Pedro H Araujo; Edson Abdala
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.

Authors:  Alessandro Russo; Simone Giuliano; Giancarlo Ceccarelli; Francesco Alessandri; Alessandra Giordano; Grazia Brunetti; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 4.  The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.

Authors:  Thomas M Baker; Michael J Satlin
Journal:  Leuk Lymphoma       Date:  2016-06-24

5.  Outcomes of critically ill cancer patients with Acinetobacter baumannii infection.

Authors:  Silvio A Ñamendys-Silva; Paulina Correa-García; Francisco J García-Guillén; María O González-Herrera; Américo Pérez-Alonso; Julia Texcocano-Becerra; Angel Herrera-Gómez; Patricia Cornejo-Juárez; Abelardo Meneses-García
Journal:  World J Crit Care Med       Date:  2015-08-04

6.  Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome.

Authors:  Jean Uwingabiye; Abdelhay Lemnouer; Sabina Baidoo; Mohammed Frikh; Jalal Kasouati; Adil Maleb; Yassine Benlahlou; Fatna Bssaibis; Albert Mbayo; Nawfal Doghmi; Khalil Abouelalaa; Abdelouahed Baite; Azeddine Ibrahimi; Mostafa Elouennass
Journal:  Germs       Date:  2017-12-05

7.  Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A.baumannii in Cancer Patient.

Authors:  Wasan Katip; Suriyon Uitrakul; Peninnah Oberdorfer
Journal:  Antibiotics (Basel)       Date:  2021-04-22

Review 8.  The prognostic factors for patients with hematological malignancies admitted to the intensive care unit.

Authors:  Qian Cheng; Yishu Tang; Qing Yang; Erhua Wang; Jing Liu; Xin Li
Journal:  Springerplus       Date:  2016-11-29

9.  Chimeric vaccine designs against Acinetobacter baumannii using pan genome and reverse vaccinology approaches.

Authors:  Fatima Shahid; Tahreem Zaheer; Shifa Tariq Ashraf; Muhammad Shehroz; Farha Anwer; Anam Naz; Amjad Ali
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

10.  Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units.

Authors:  Jean Uwingabiye; Mohammed Frikh; Abdelhay Lemnouer; Fatna Bssaibis; Bouchra Belefquih; Adil Maleb; Souhail Dahraoui; Lahcen Belyamani; Abdelouahed Bait; Charki Haimeur; Lhoussain Louzi; Azeddine Ibrahimi; Mostafa Elouennass
Journal:  Pan Afr Med J       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.